Lv1
100 积分 2026-01-07 加入
Inhalable Polymeric PROTAC Nanococktail for Targeted Protein Degradation in Idiopathic Pulmonary Fibrosis
2个月前
已完结
In vivo pharmacokinetic and pharmacodynamic study of co-spray-dried inhalable pirfenidone microparticles in rats
2个月前
已关闭
Multicenter Population Pharmacokinetics and Exposure–Efficacy Analysis of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
3个月前
已完结
Multicenter Population Pharmacokinetics and Exposure–Efficacy Analysis of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
3个月前
已完结
Nintedanib combined with pirfenidone in patients with idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF): a retrospective multicentre study (Combi-PF)
3个月前
已关闭
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
3个月前
已完结
Role of 'dual Antifibrotic combination' Nintedanib plus Pirfenidone in Idiopathic Pulmonary Fibrosis: A favourable outcome & recommendation to change from monotherapy to combination regimen in a single center experience of 105 IPF cases
4个月前
已关闭
Development of a novel method for the continuous blending of carrier-based dry powders for inhalation using a co-rotating twin-screw extruder
4个月前
已完结
Mixing of dry powders for inhalation: A review
4个月前
已完结
Hypoxia enhances the production and antitumor effect of exosomes derived from natural killer cells
8个月前
已完结
皖公网安备34019202002308
